[
    [
        {
            "time": "",
            "original_text": "【光大医药 | 年报点评】同仁堂：经营调整拖累短期业绩，营运质量有所提升 盈利能力下降",
            "features": {
                "keywords": [
                    "同仁堂",
                    "经营调整",
                    "短期业绩",
                    "营运质量",
                    "盈利能力"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【光大医药 | 年报点评】同仁堂：经营调整拖累短期业绩，营运质量有所提升 盈利能力下降",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "百亿中药企业交卷，白云山、云南白药、同仁堂、华润三九哪家强？",
            "features": {
                "keywords": [
                    "中药企业",
                    "白云山",
                    "云南白药",
                    "同仁堂",
                    "华润三九"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "百亿中药企业交卷，白云山、云南白药、同仁堂、华润三九哪家强？",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "第一上海丨同仁堂国药（3613，买入）：疫情冲击短期业绩，不改长期增长逻辑",
            "features": {
                "keywords": [
                    "同仁堂国药",
                    "疫情",
                    "短期业绩",
                    "长期增长逻辑"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "第一上海丨同仁堂国药（3613，买入）：疫情冲击短期业绩，不改长期增长逻辑",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]